Warning letterFDA · Aug 27, 2024
SoloVital MARCS-CMS 688046, August 27, 2024
Named company: SoloVital
As described below, this product is an unapproved new drug introduced or delivered for introduction into interstate commerce in violation of sections 505(a) and 301(d) of the Federal Food, Drug, and…
Lot information: not specified in this record.
